What aspects of strategic adaptation in transitioning to CSA would make for a valuable deep-dive session, particularly in regulated environments?
What were the most impactful learnings from ElevateBio’s transition, and how could a future session focus on these lessons to benefit other organizations considering similar changes?
How could we create a session around best practices or guidance for qualifying MES and eBRs within a CSA framework, highlighting the key differences from CSV?
What session topics could explore the broader industry implications of moving from CSV to CSA, particularly around agility, compliance, and innovation in digital transformation?